AI visibility score
3.6/ 10Weak

#634,865 of 925,124 in Healthcare

As of 2026-08-08 · Engagemii indexCheck another site →Live terminal →

AI Visibility Scorecard

Viatris Pretomanid Named Patient Access Program for MDR TB

Viatris Pretomanid Named Patient Access Program for MDR TB

Unclaimed

accesspretomanid.com · Healthcare

Borderline visible. AI bots can crawl Viatris Pretomanid Named Patient Access Program for MDR TB, but the structured-data signals are thin - you are at real risk of being skipped when buyers ask ChatGPT, Claude, or Perplexity for a recommendation.

AI engines read this profile 6 times

Claude · Apple Intelligence · ChatGPT · Meta AI

#634,865 of 925,124 in Healthcare for AI visibility

<1

AI Naming Predictability

i

Rarely named · <1/100

Top 83% of Healthcare

4

AEO Visibility

i

Near-invisible · 3.6/10

5

Muse Index Score

i

AI agent readiness

Basic · 5/100

0

AI Adoption

i

None detected · 0/100

Share

About Viatris Pretomanid Named Patient Access Program for MDR TB

from our crawl and measurement

"‘Named Patient Access Programs’ help address this need by providing eligible patients access to certain unapproved or investigational treatments which are approved in other countries." That is how Viatris Pretomanid Named Patient Access Program for MDR TB introduces itself. When AI engines look at it, they find little to work with. It scores 3.6 out of 10.

Our crawl found a sitemap and a readable heading structure. It is missing structured data describing the business and an llms.txt file.

AI crawlers have visited 2 times in our tracking, including ClaudeBot (Anthropic) and Applebot (Siri).

Industry · Healthcare
Last scored · Aug 8, 2026

The 6 signals AI reads

Strong · Good · Fair · Weak

Structured Data

Weak

Organization / LocalBusiness JSON-LD that AI can read.

Content Structure

Strong

Clear headings and answer-style content.

Entity Clarity

Fair

How clearly your brand identity reads to AI.

E-E-A-T Signals

Experience, Expertise, Authority, Trust

Fair

Experience, Expertise, Authority, Trust markers.

Technical AEO

Good

robots.txt, llms.txt, and AI-bot crawl access.

AI Discoverability

Fair

Sitemaps and entity links AI can follow.

Off-page authority

How the web signals your brand to AI

Backlinks

Weak

No inbound links found yet.

Domain Authority

Weak

Little domain authority yet.

Reference Presence

Weak

Not in AI knowledge graphs yet.

News & Press

Weak

No press coverage found yet.

Community

Weak

No community discussion yet.

Social Mentions

Weak

No social discussion found yet.

What this score means

Your AEO score measures whether AI search engines - ChatGPT, Claude, Perplexity, Gemini - can actually read your site and cite it in answers. Roughly two-thirds of sites are invisible to them. At 3.6/10, Viatris Pretomanid Named Patient Access Program for MDR TB is crawlable but under-signaled - fixable, and the signals above are where to start.

Frequently Asked Questions

WHAT IS PRETOMANID’S NPAP ACCESS PROGRAM?

Tuberculosis (TB) is the world’s leading cause of death from a single infectious disease. In 2021, an estimated 10.6 million people developed TB. There were an estimated 1.4 million TB deaths among Human Immunodeficiency Virus (HIV) - negative people in 2021 and an additional 187,000 deaths among HIV-positive people.

Is this your brand?

✓

The exact fixes for Viatris Pretomanid Named Patient Access Program for MDR TB

✓

Which AI engines already crawl you

✓

Free AI bot monitoring: see every AI crawler that visits you

Claim your page free

Already have an account? Sign in

Picked for Viatris Pretomanid Named Patient Access Program for MDR TB: How-To

How to Get Your Brand Cited by ChatGPT, Gemini, and Claude: The Complete AEO Guide

The search landscape has fundamentally shifted. While Google still dominates, millions of users now ask questions to ChatGPT, Gemini, and Claude instead of typing into a search bar.

Continue reading in your free Engagemii portal

Free signup unlocks the full article plus your personalized AEO fix list for Viatris Pretomanid Named Patient Access Program for MDR TB.

Source & Attribution

Scored by Engagemii on August 8, 2026. Methodology: engagemii.com/aeo/methodology

Source URL: https://engagemii.com/aeo/brands/accesspretomanid

Cite this score: Engagemii (2026). "AEO Score for Viatris Pretomanid Named Patient Access Program for MDR TB." Retrieved from https://engagemii.com/aeo/brands/accesspretomanid

Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.

Powered by Engagemii - The Answer Engine Optimization (AEO) Platform